» Articles » PMID: 14758080

Human Galectin-8 Isoforms and Cancer

Overview
Journal Glycoconj J
Publisher Springer
Date 2004 Feb 6
PMID 14758080
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Galectins are animal lectins that can specifically bind beta-galactosides. Thirteen galectins have already been described. This review focuses on a specific member of this family: galectin-8. This galectin was discovered in prostate cancer cells eight years ago and has been studied extensively in the last few years. The galectin-8 gene ( LGALS8) encodes numerous mRNAs by alternate splicing and the presence of three unusual polyadenylation signals. These mRNAs encode six different isoforms of galectin-8: three belong to the tandem-repeat galectin group (with two CRDs linked by a hinge peptide) and three to the prototype group (with one CRD). Various studies showed that galectin-8 is widely expressed in tumor tissues as well as in normal tissues. The level of galectin-8 expression may correlate with the malignancy of human colon cancers and the degree of differentiation of lung squamous cell carcinomas and neuro-endocrine tumors. Recently, the differences in galectin-8 expression levels between normal and tumor tissues have been used as a guide for the selection of strategies for the prevention and treatment of lung squamous cell carcinoma. These experiments are still under investigation, but demonstrate the potential of galectin-8 research to enhance our understanding of, and possibly prevent, the process of neoplastic transformation.

Citing Articles

Galectin-8N-Selective 4-Halophenylphthalazinone-Galactals Double π-Stack in a Unique Pocket.

van Klaveren S, Hassan M, Hakansson M, Johnsson R, Larsson J, Jakopin Z ACS Med Chem Lett. 2024; 15(8):1319-1324.

PMID: 39140038 PMC: 11318003. DOI: 10.1021/acsmedchemlett.4c00212.


The role of galectins in mediating the adhesion of circulating cells to vascular endothelium.

Souchak J, Mohammed N, Lau L, Dimitroff C Front Immunol. 2024; 15:1395714.

PMID: 38840921 PMC: 11150550. DOI: 10.3389/fimmu.2024.1395714.


Inhibition of sugar-binding activity of Galectins-8 by thiogalactoside (TDG) attenuates secondary brain damage and improves long-term prognosis following intracerebral hemorrhage.

Song J, Bai H, Chen S, Xing Y, Lou J Heliyon. 2024; 10(9):e30422.

PMID: 38737270 PMC: 11088311. DOI: 10.1016/j.heliyon.2024.e30422.


Sex Differences in Cochlear Transcriptomes in Horseshoe Bats.

Wu J, Duan C, Lan L, Chen W, Mao X Animals (Basel). 2024; 14(8).

PMID: 38672325 PMC: 11047584. DOI: 10.3390/ani14081177.


Significance of the Galectin-8 Immunohistochemical Profile in Ovarian Cancer.

Avadanei E, Caruntu I, Amalinei C, Pavaleanu I, Giusca S, Rusu A Biomedicines. 2024; 12(2).

PMID: 38397905 PMC: 10887174. DOI: 10.3390/biomedicines12020303.


References
1.
Gopalkrishnan R, Roberts T, Tuli S, Kang D, Christiansen K, Fisher P . Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human galectin-8 related gene. Oncogene. 2000; 19(38):4405-16. DOI: 10.1038/sj.onc.1203767. View

2.
Nagy N, Bronckart Y, Camby I, Legendre H, Lahm H, Kaltner H . Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut. 2002; 50(3):392-401. PMC: 1773143. DOI: 10.1136/gut.50.3.392. View

3.
Danielsen E, van Deurs B . Galectin-4 and small intestinal brush border enzymes form clusters. Mol Biol Cell. 1997; 8(11):2241-51. PMC: 25705. DOI: 10.1091/mbc.8.11.2241. View

4.
Bassen R, Brichory F, Caulet-Maugendre S, Bidon N, Delaval P, Desrues B . Expression of Po66-CBP, a type-8 galectin, in different healthy, tumoral and peritumoral tissues. Anticancer Res. 2000; 19(6B):5429-33. View

5.
Desrues B, Brichory F, Lena H, Bourguet P, Delaval P, Toujas L . Treatment of human lung carcinoma xenografts with a combination of 131I-labelled monoclonal antibody Po66 and doxorubicin. Cancer Immunol Immunother. 1996; 43(5):269-74. PMC: 11037616. DOI: 10.1007/s002620050333. View